Incyte kündigt positive Ergebnisse aus Phase-3-Studie zur Bewertung von Retifanlimab (Zynyz ®) in Kombination mit platinbasierter Chemotherapie bei Patienten mit nicht-kleinzelligem Lungenkrebs an.
Before you receive ZYNYZ, tell your healthcare provider about all of your medical conditions, including if you: have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus have received an organ transplant have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic) have received radiation treatment to … Weiterlesen